AKT1 and Hyperglycemia: As a target of peroxisome proliferator-activated receptor γ (PPAR γ), FAM3A has been shown to inhibit hyperglycemia and insulin resistance via the PI3K/AKT signaling pathway (Song et al. 2017; Wang et al. 2014).